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2–5% of patients undergoing hip or knee arthroplasty develop a symptomatic DVT; there is evidence to suggest that without
prophylaxis 40–60% of patients have a subclinical DVT. This can be reduced by around half with appropriate thromboprophylaxis;
there still remains a signiﬁcant incidence of subclinical DVT. Therefore, it is important to know, as orthopaedic surgeons, if our
patients undergoing large joint arthroplasty are being adversely aﬀected. Post-thrombotic syndrome (PTS) is usually associated
with symptomatic DVT, and the purpose of this paper is to address if asymptomatic DVT is also associated with an increased risk
of PTS. The majority of evidence gathered does not support a link; therefore, there is no evidence to warrant a change in practice
to warn patients of a potential risk or to routinely screen asymptomatic patients.
1.Introduction
There are signiﬁcant risks of deep vein thrombosis
(DVT) inpatients when undergoing large joint arthroplasty.
Although 2–5% of patients develop a symptomatic DVT,
studies have shown that between 40 and 60% of all patients
studied with venography [1]a r ef o u n dt oh a v eaD V T .T h i s
risk is reduced by around 50% with the use of perioperative
andextendedthromboprophylaxis.However,thereremainsa
signiﬁcant number of patients who develop subclinical DVT
that is not identiﬁed.
Post-thrombotic syndrome (PTS) is characterised by
aching pain on standing and dependent oedema. The
development of lipodermatosclerosis, pruritis, and exema-
tous change are also features, as is secondary development
of venous varicosities. Patients aﬀected may suﬀer from
ulceration of the skin due to microtrauma which has a high
likelihood of recurrence [2]. A diagnosis is made based on
the development of these symptoms and signs with a history
of DVT [2].
A Review of 12 prospective studies which recorded the
onset of symptoms following a symptomatic DVT (by Kahn
and Ginsberg) suggests that 20–50% of patients develop PTS
within 1-2 years, with severe symptoms including ulceration
in 5–10% of cases [3].
The incidence of PTS associated with symptomatic DVT
must then raise the question, are patients with asymptomatic
DVT that is not identiﬁed also at a signiﬁcant risk? Are
there signiﬁcant numbers of patients not being identiﬁed
as PTS as their DVT was subclinical? If this is the case
then is it important that orthopaedic surgeons and the
multidisciplinary team are more aware of the features to
identify PTS and treat it accordingly. Treatment commonly
includes compression bandaging, graduated elastic compres-
sion stockings, dressings, and elevation.
Itisalsoimportantaspartofanypreoperativecounseling
for arthroplasty when all potential relevant risks to the
patient associated with the proposed surgery are discussed
to obtain informed consent. Therefore, it is important to
identify if there is an increased risk and if so quantify it so
that the patient can make a fully reasoned decision.
2. Thromboprophylaxis
Thromboprophylaxis is an essential consideration in all
patients undergoing large joint arthroplasty. The onset of
venous thromboembolism is best classiﬁed chronologically
as occurring pre-op or post-op, and measures can be put
in place in each of these time frames in an attempt to2 Thrombosis
provide protection. The United Kingdom NICE guidelines
[4] on thromboprophylaxis in surgical patients advocate a
range of measures including stopping oestrogen contain-
ing hormone replacements (including the combined oral
contraceptive pill) 4 weeks prior to elective surgery, using
regional anaesthesia where possible due to the reduced
risk of thromboembolic event and beginning of mechanical
prophylaxis on admission.
Mechanical prophylaxis is often used as an adjunct to
pharmaceutical therapy and has been found to provide
a similar degree of protection to patients after total hip
arthroplasty as low-molecular-weight heparins when used
in a controlled and speciﬁcally designed program [5]. One
must also consider the risks of pharmaceutical prophylaxis
as a factor in deciding on the most appropriate thrombopro-
phylaxis. In reducing the risk of developing postthrombotic
syndrome, elastic compression stockings have been shown to
be of beneﬁt. For this reason, the American College of Chest
physicians recommends wearing compression stockings for
two years following DVT [6].
Postoperativethromboprophylaxisisbestachievedbythe
combination of pharmaceutical and mechanical prophylaxis.
The NICE guidelines [4] advise starting pharmacological
prophylaxis within 12 hours postoperatively depending on
the agent in use, provided there are no contraindications.
In reducing the risk of developing postthrombotic syn-
drome, graduated elastic compression stockings have been
shown to be of beneﬁt [7] .As y s t e m a t i cr e v i e wo ft w o
studies has shown that extended prophylaxis can reduce the
incidence of symptomatic DVT from 2.7% to 1.1% [8],
although the length of treatment is unclear.
3. What CausesPTSAnd How IsIt Identiﬁed?
DVT treatment with anticoagulation aims to prevent clot
propagation, but does not act to lyse the existing thrombus
[9]. “The clinical manifestations of PTS are probably due to
venous hypertension. Venous hypertension occurs as a con-
sequence of venous valvular incompetence, persistent deep
vein outﬂow obstruction, or both valvular incompetence
results from damage to venous valves at the time of the
acute DVT, or during the process of vein re-cannulisation
after DVT. If re-cannulisation is incomplete, venous outﬂow
obstructionoccursandleads to the development ofcollateral
circulation via the superﬁcial and perforator veins, which
may gradually become incompetent and varicose due to
progressive dilation. Venous hypertension, the end result of
these processes, leads to the appearance of telangiectasiae
and venous ectasia, and causes capillary leakage of plasma
proteins, erythrocytes and leukocytes, with resultant edema,
tissue hypoxia and damage, and ultimately, in some cases,
skin ulceration” [3].
The Villalta scale was proposed in the 1990s as a clinical
scale to diagnose and classify the severity of PTS. This
has since been accepted as a reliable and valid measure of
PTS. The score grades the severity of symptoms, grading
each symptoms from 0 (mild) to 3 (severe). There are 12
symptoms and signs taken into account. The symptoms are
pain, cramps, heaviness, pruritis, and parasthesia. The signs
are oedema, redness, skin induration, hyperpigmentation,
venous ectasia, and pain on calf compression. The scores
for each feature are added, and a score of 5 or above is
indicative of PTS. 5–9 is considered mild, 10–14 moderated
and above 14 severe [10]. A second classiﬁcation, the CEAP
classiﬁcation (clinical, aetiological, anatomical, and patho-
physiological) is also available to be used in the classiﬁcation
of PTS [2]. This classiﬁcation is useful particularly for
medical practitioners as a descriptive tool rather than a
measure of the severity of PTS.
4.RelevantStudiesRelatedto
Orthopaedic Surgery
We conducted a literature search using NHS Knowledge
Network Athens and PubMed, identifying 8 papers relevant
to this review. These papers were conducted between 1994
and2001.Thekeywords,arthroplasty,PTS,subclinicalDVT,
orthopaedic, TKR, and THR, were searched for. Studies with
a standard assessment for each group were included. Level 3
evidence and below were excluded.
Some of the studies suggest that there is a link between
asymptomatic DVT and development of PTS. McNally et al.
[11] reviewed 43 patients 5 years after total hip replacement
(THR).Allhadavenogramatthetimeofsurgery;41patients
were asymptomatic although 11 patients were found to have
a DVT. At 5 years, the syndrome was found to be present
in 9 of the 11 patients with recorded DVT, although it was
also present in 4 patients without DVT. Siragusa et al. [12]
reviewed 98 patients who underwent a mix of both THR and
total knee replacement (TKR) 2 to 4 years postoperatively.
46 (46.9%) were found to have an asymptomatic DVT. 23%
of the patients with asymptomatic DVT were identiﬁed as
having PTS.
However, there are also studies which cast doubt upon
the likelihood of that link. Lonner et al. [13]r e v i e w e d
203 limbs (186 patients) who underwent a mix of THR
and TKRs. Routine venography was performed post-op
and patients were contacted at least 7 years postopera-
tively. No signiﬁcant increase in risk of PTS was identiﬁed
after asymptomatic proximal or distal DVT. Warwick et
al. [14] reviewed 134 (64 patients) limbs following THR
between 14 and 21 years. 98 limbs were found to have a
positive ﬁbrinogen uptake test. However, chronic venous
insuﬃciency was found in 4 of 13 (12%) unaﬀected limbs
and in only 11 out of 98 (11%) aﬀected limbs. Suggesting
chronic venous insuﬃciency was not associated with a
positive test at 14–21 years. Ginsberg et al. [15]r e v i e w e d
255 patients who underwent TKR or THR between 2 and
7 years postoperatively. Prior to discharge, all patients had
routine venography. There were 25 proximal DVT and 66
distal DVT identiﬁed. There was no DVT in 164 patients. At
followup, only 1 (4%) with proximal DVT and 4 (6.1%) with
distal DVT had symptoms consistent with PTS. 7 (4.1%)
of patients with no DVT identiﬁed were also identiﬁed as
ﬁtting the criteria for PTS. Deehan et al. [16] followed up
a cohort of 405 patients who underwent TKR. Patients wereThrombosis 3
not screened for DVT unless there was clinical indication. 9
patients were identiﬁed as having a DVT post-op and treated
with low-molecular-weight heparin. At review, between 2–
10 years, 52 patients (13%) had developed PTS, including
9 of the patients identiﬁed as having a postoperative DVT.
Mant et al. [17] reviewed 188 patients who underwent THR.
Venography was conducted postoperatively, and 25 (13%)
patients were found to have a DVT. Patients were followed
up at 2 years, and 12 (6%) patients had developed symptoms
consistent with PTS, 7 of the patients experiencing bilateral
symptoms. However, only 4 of the limbs suggestive of PTS
were in patients identiﬁed as having had a DVT.
5. Discussion
The majority of research does not support a link between
large joint arthroplasty and Post-thrombotic syndrome.
Studies by Siragussa and McNally with a combined number
of 141 patients appear to show an increased incidence of
PTS in patients with asymptomatic DVT. However, 5 studies
by Lonner, Warwick, Ginsberg, Deehan, and Mant, with a
combined number of 1098 patients, found no direct link.
Whilst PTS is a condition that orthopaedic surgeons
should be mindful of, the majority of research done does
not support an increased risk associated with large joint
arthroplasty. Therefore, at this time, there is no evidence to
changecurrentpracticeintheconsentingofpatientsforTHR
or TKR’s, or to screen symptomatic postoperative patients.
However, in many countries, such as in Scotland, there is
a national arthroplasty audit system in place. This could
be very useful way to use existing infrastructure to run a
prospective national multicentre study through with a view
to arriving at a deﬁnitive answer.
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